COM:BEAMTX
Beam Therapeutics
- Stock
Last Close
23.58
22/11 21:00
Market Cap
2.40B
Beta: -
Volume Today
1.16M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -8.00M - | -116.74M 1,358.86% | -78.33M 32.90% | -194.59M 148.44% | -370.64M 90.47% | -289.09M 22.00% | -132.53M 54.16% | |
depreciation and amortization | 11K - | 650K 5,809.09% | 3.50M 438.92% | 4.74M 35.17% | 7.45M 57.36% | 14.15M 89.87% | 20.01M 41.46% | |
deferred income tax | 500K - | 11.75M 2,249.80% | 4.48M 61.87% | 63.52M 1,317.81% | -16.77M 126.39% | -146.40M - | ||
stock based compensation | 198K - | 7.00M 3,436.36% | 7.03M 0.37% | 15.38M 118.84% | 43.57M 183.29% | 84.32M 93.53% | 98.65M 16.99% | |
change in working capital | 740K - | 10.07M 1,261.49% | -10.71M 206.25% | 5.35M 149.95% | 111.25M 1,980.68% | 251.63M 126.17% | -116.45M 146.28% | |
accounts receivables | -300M - | 300M 200% | -146K 100.05% | |||||
inventory | 300M - | -300M 200% | ||||||
accounts payables | 726K - | 2.44M 235.54% | 4.09M 67.98% | 60K 98.53% | 818K 1,263.33% | 2.37M 190.10% | -7.58M 419.34% | |
other working capital | 14K - | 7.64M 54,464.29% | -14.80M 293.70% | 5.29M 135.73% | 110.44M 1,988.82% | 249.25M 125.70% | -108.73M 143.62% | |
other non cash items | 3.85M - | 66.96M 1,641.13% | 2.02M 96.99% | 9.87M 389.39% | 158.86M 1,509.36% | -38.48M 124.22% | 127.52M 431.39% | |
net cash provided by operating activities | -2.71M - | -20.30M 649.83% | -72.00M 254.73% | -95.74M 32.97% | -66.27M 30.78% | 22.53M 133.99% | -149.19M 762.29% | |
investments in property plant and equipment | -346K - | -13.12M 3,693.06% | -12.52M 4.62% | -16.36M 30.67% | -46.81M 186.18% | -48.95M 4.57% | -33.73M 31.09% | |
acquisitions net | 54.14M - | 83.77M 54.72% | 620K 99.26% | 412.38M 66,413.71% | ||||
purchases of investments | -300K - | -130.21M 43,303.33% | -282.36M 116.85% | -777.22M 175.26% | -1.62B 108.05% | -984.34M 39.13% | ||
sales maturities of investments | 76.07M - | 198.60M 161.07% | 529.27M 166.51% | 1.20B 127.60% | 1.09B 9.52% | |||
other investing activites | -54.14M - | -83.77M 54.72% | -412.38M - | |||||
net cash used for investing activites | -346K - | -13.42M 3,779.77% | -66.66M 396.57% | -100.12M 50.20% | -294.14M 193.78% | -461.34M 56.84% | 71.84M 115.57% | |
debt repayment | -464K - | -1.57M 238.15% | -2.12M 34.99% | -2.29M 7.98% | -2.25M 1.53% | |||
common stock issued | 37.90M - | 319.53M 743.06% | 757.45M 137.05% | 108.26M 85.71% | 278.70M 157.44% | |||
common stock repurchased | -25.19M - | |||||||
dividends paid | -12.71M - | |||||||
other financing activites | 4.98M - | 179.73M 3,506.08% | 41.74M 76.77% | 4.36M 89.55% | 810K 81.43% | 5.62M 593.70% | ||
net cash used provided by financing activities | 4.98M - | 179.73M 3,506.08% | 41.28M 77.03% | 322.32M 680.84% | 756.14M 134.59% | 111.59M 85.24% | 276.45M 147.74% | |
effect of forex changes on cash | -197.69M - | |||||||
net change in cash | 1.93M - | 146.00M 7,461.11% | -97.38M 166.70% | 126.46M 229.86% | 395.73M 212.93% | -327.22M 182.69% | 203.13M 162.08% | |
cash at beginning of period | 1.93M - | 147.94M 7,561.11% | 50.55M 65.83% | 177.01M 250.15% | 572.74M 223.56% | 232.77M 59.36% | ||
cash at end of period | 1.93M - | 147.94M 7,561.11% | 50.55M 65.83% | 177.01M 250.15% | 572.74M 223.56% | 245.52M 57.13% | 435.89M 77.54% | |
operating cash flow | -2.71M - | -20.30M 649.83% | -72.00M 254.73% | -95.74M 32.97% | -66.27M 30.78% | 22.53M 133.99% | -149.19M 762.29% | |
capital expenditure | -346K - | -13.12M 3,693.06% | -12.52M 4.62% | -16.36M 30.67% | -46.81M 186.18% | -48.95M 4.57% | -33.73M 31.09% | |
free cash flow | -3.05M - | -33.42M 994.73% | -84.52M 152.89% | -112.10M 32.63% | -113.08M 0.88% | -26.42M 76.63% | -182.93M 592.28% |
All numbers in USD (except ratios and percentages)